165 related articles for article (PubMed ID: 37848946)
21. p53 in breast cancer subtypes and new insights into response to chemotherapy.
Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
[TBL] [Abstract][Full Text] [Related]
22. Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis.
McCubrey JA; Lertpiriyapong K; Fitzgerald TL; Martelli AM; Cocco L; Rakus D; Gizak A; Libra M; Cervello M; Montalto G; Yang LV; Abrams SL; Steelman LS
Adv Biol Regul; 2017 Jan; 63():32-48. PubMed ID: 27776972
[TBL] [Abstract][Full Text] [Related]
23. Prognostic implications and interaction of L1 methylation and p53 expression statuses in advanced gastric cancer.
Shin YJ; Kim Y; Wen X; Cho NY; Lee S; Kim WH; Kang GH
Clin Epigenetics; 2019 May; 11(1):77. PubMed ID: 31088544
[TBL] [Abstract][Full Text] [Related]
24. PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression.
Uchi R; Kogo R; Kawahara K; Sudo T; Yokobori T; Eguchi H; Sugimachi K; Maehama T; Mori M; Suzuki A; Komune S; Mimori K
Br J Cancer; 2013 Oct; 109(8):2199-206. PubMed ID: 24045667
[TBL] [Abstract][Full Text] [Related]
25. Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.
van Beek EJAH; Hernandez JM; Goldman DA; Davis JL; McLaughlin K; Ripley RT; Kim TS; Tang LH; Hechtman JF; Zheng J; Capanu M; Schultz N; Hyman DM; Ladanyi M; Berger MF; Solit DB; Janjigian YY; Strong VE
Ann Surg Oncol; 2018 Jul; 25(7):2027-2033. PubMed ID: 29725898
[TBL] [Abstract][Full Text] [Related]
26. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort.
Schoop I; Maleki SS; Behrens HM; Krüger S; Haag J; Röcken C
Hum Pathol; 2020 Nov; 105():53-66. PubMed ID: 32971129
[TBL] [Abstract][Full Text] [Related]
27. Alterations of the TP53 gene in gastric and esophageal carcinogenesis.
Bellini MF; Cadamuro AC; Succi M; Proença MA; Silva AE
J Biomed Biotechnol; 2012; 2012():891961. PubMed ID: 22919278
[TBL] [Abstract][Full Text] [Related]
28. Selective pericentromeric heterochromatin dismantling caused by TP53 activation during senescence.
Mendez-Bermudez A; Lototska L; Pousse M; Tessier F; Croce O; Latrick CM; Cherdyntseva V; Nassour J; Xiaohua J; Lu Y; Abbadie C; Gagos S; Ye J; Gilson E
Nucleic Acids Res; 2022 Jul; 50(13):7493-7510. PubMed ID: 35819196
[TBL] [Abstract][Full Text] [Related]
29. Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer.
Tahara T; Shibata T; Okamoto Y; Yamazaki J; Kawamura T; Horiguchi N; Okubo M; Nakano N; Ishizuka T; Nagasaka M; Nakagawa Y; Ohmiya N
Oncotarget; 2016 Jul; 7(27):42252-60. PubMed ID: 27323394
[TBL] [Abstract][Full Text] [Related]
30. UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma.
Mudbhary R; Hoshida Y; Chernyavskaya Y; Jacob V; Villanueva A; Fiel MI; Chen X; Kojima K; Thung S; Bronson RT; Lachenmayer A; Revill K; Alsinet C; Sachidanandam R; Desai A; SenBanerjee S; Ukomadu C; Llovet JM; Sadler KC
Cancer Cell; 2014 Feb; 25(2):196-209. PubMed ID: 24486181
[TBL] [Abstract][Full Text] [Related]
31. Zebrafish imaging reveals TP53 mutation switching oncogene-induced senescence from suppressor to driver in primary tumorigenesis.
Haraoka Y; Akieda Y; Nagai Y; Mogi C; Ishitani T
Nat Commun; 2022 Mar; 13(1):1417. PubMed ID: 35304872
[TBL] [Abstract][Full Text] [Related]
32. Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc.
Lee DH; Kim GW; Yoo J; Lee SW; Jeon YH; Kim SY; Kang HG; Kim DH; Chun KH; Choi J; Kwon SH
Cell Death Dis; 2021 Jan; 12(1):89. PubMed ID: 33462212
[TBL] [Abstract][Full Text] [Related]
33. Induction of accelerated senescence by gamma radiation in human solid tumor-derived cell lines expressing wild-type TP53.
Mirzayans R; Scott A; Cameron M; Murray D
Radiat Res; 2005 Jan; 163(1):53-62. PubMed ID: 15606307
[TBL] [Abstract][Full Text] [Related]
34. Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53.
Gadhikar MA; Sciuto MR; Alves MV; Pickering CR; Osman AA; Neskey DM; Zhao M; Fitzgerald AL; Myers JN; Frederick MJ
Mol Cancer Ther; 2013 Sep; 12(9):1860-73. PubMed ID: 23839309
[TBL] [Abstract][Full Text] [Related]
35. Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous?
Nakayama T; Ling ZQ; Mukaisho K; Hattori T; Sugihara H
BMC Cancer; 2010 Jun; 10():311. PubMed ID: 20565940
[TBL] [Abstract][Full Text] [Related]
36. Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3.
Maeda M; Takeshima H; Iida N; Hattori N; Yamashita S; Moro H; Yasukawa Y; Nishiyama K; Hashimoto T; Sekine S; Ishii G; Ochiai A; Fukagawa T; Katai H; Sakai Y; Ushijima T
Gut; 2020 Feb; 69(2):243-251. PubMed ID: 31085554
[TBL] [Abstract][Full Text] [Related]
37. PIK3CA somatic mutations as potential biomarker for immunotherapy in elder or TP53 mutated gastric cancer patients.
Yao J; You Q; Zhang X; Zhang Y; Xu J; Zhao X; Li J; Wang X; Gong Z; Zhang D; Wang W
Clin Genet; 2023 Feb; 103(2):200-208. PubMed ID: 36346122
[TBL] [Abstract][Full Text] [Related]
38. miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells.
Neault M; Mallette FA; Richard S
Cell Rep; 2016 Mar; 14(8):1966-78. PubMed ID: 26904954
[TBL] [Abstract][Full Text] [Related]
39. Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer.
Qadir J; Majid S; Khan MS; Rashid F; Wani MD; Bhat SA
Pathol Oncol Res; 2021; 27():1609826. PubMed ID: 34924820
[TBL] [Abstract][Full Text] [Related]
40. Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing.
Shajani-Yi Z; de Abreu FB; Peterson JD; Tsongalis GJ
Neoplasia; 2018 Mar; 20(3):256-262. PubMed ID: 29454261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
